Hillgene vs Omniabio

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/hillgene/omniabio

Category	Hillgene	Omniabio
Listed site	cdmo	cdmo
Summary	Hillgene is a leading CDMO provider specializing in cell therapy manufacturing, offering end-to-end solutions for CAR-T, TCR-T, CAR-NK, and UCAR-T cell therapies with GMP facilities in Suzhou and Belgium.	OmniaBio is a cell and gene therapy CDMO specializing in process development, analytical development, and GMP manufacturing for lentiviral vectors, iPSCs, and immune cell-based therapies. The company operates a 120,000 sq ft facility in Hamilton, Ontario, integrating AI, automation, and robotics to deliver scalable manufacturing from preclinical to commercial stages.
Services	Cell Therapy Manufacturing Autologous Cell Therapy Manufacturing Allogeneic Cell Therapy Manufacturing Lentiviral Vector Manufacturing mRNA Manufacturing Quality Control Testing Regulatory Affairs CMC Regulatory Submission Support	Process Development CMC Analytical Development Cell-Line Development Autologous Cell Therapy Manufacturing Allogeneic Cell Therapy Manufacturing Cell Therapy Manufacturing Lentiviral Vector Manufacturing CMC Regulatory Submission Support
Modalities	Cell Therapy mRNA Gene Therapy	Cell Therapy Gene Therapy
Indications	Oncology Immunology	Data not yet provided.
Locations	Headquarters, Suzhou, Jiangsu, China R&D Center, Suzhou, Jiangsu, China GMP Facility, Belgium, Belgium	Headquarters & Manufacturing Facility, Hamilton, Ontario, Canada
Certifications	FDA · Identifier: DMF filing approval for genetically modified K562 feeder cells	Data not yet provided.
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.